Novel alkyl hydrogen phosphonate derivatives of the anti-HIV nucleoside analogue AZT have been prepared by phosphorochloridite chemistry. These materials are designed to act as labile membrane-soluble prodrugs of the bioactive free nucleotides. In vitro evaluation has revealed the compounds to have a pronounced and selective antiviral action. Short-chain (C1-C7) alkyl derivatives are more potent than the parent hydrogen phosphonate, whilst one long-chain (C18) compound is less active. In an assay that demonstrates the toxicity of the parent drug AZT, the alkyl H-phosphonates appear to be less cytotoxic, whilst retaining full antiviral activity. Lastly, the compounds are all poorly active in a cell line (JM) that is poorly responsive to AZT, indicating that they act as depot forms of the nucleoside rather than of the free nucleotide.
References
1.
BetbederD.HutchinsonD.W.RichardsA.O'LMahmoodN., and KinchingtonD. (1990) The enzymatic synthesis and anti-HIV-1 activity of 9-β-D-2′,3′-dideoxynucleosides of N(6)-substituted purines. Antiviral Chem Chemother1: 241–247.
2.
CohenS.S., and PlunkettW. (1975) The utilisation of nucleotides by animal cells. Ann NY Acad Sci255: 269–286.
3.
DevineK.G.McGuiganC.O'ConnorT.J.NichollsS.R., and KinchingtonD. (1990) Novel phosphate derivatives of zidovudine as anti-HIV compounds. AIDS4: 371–372.
4.
FarrowS.N.JonesA.S.KumarA.WalkerR.T.BalzariniJ., and De ClercqE. (1990) Synthesis and biological properties of novel phosphotriesters: A new approach to the introduction of biologically active nucleotides into cells. J Med Chem33: 1400–1406.
5.
FreedJ.FarquharD., and HamptonA. (1989) Evidence for acyloxymethyl esters of pyrimidine 5′-deoxyribonucleotides as extracellular sources of active 5′-deoxyribonucleotides in cultured cells. Biochem Pharmacol38: 3193–3198.
6.
GareggP.J.RegbergT.StawinskiJ., and StrömbergR. (1986) Nucleoside hydrogen phosphonates in oligonucleotide synthesis. Chem Script26: 59–62.
7.
HeninY.GouyetteC.SchwartO.DebouzyJ.-C.NeumannJ.-M., and Huynh-DinhT. (1991) Lipophilic glycosyl phosphotriester derivatives of AZT: Synthesis, NMR transmembrane transport study and antiviral activity. J Med Chem34: 1830–1837.
8.
KarpasA.FleetG.W.J.DwekR.A.PeturssonS.NamgoongS.K.RamsdenN.G.JacobG.S., and RademacherT.W. (1988) Amino sugar derivatives as potential anti-human immunodeficiency virus agents. Proc Natl Acad Sci USA85: 9229–9233.
9.
KrayevskyA.A.TarussovaN.B.ZhuQ.-Y.VidalP.ChouT.-C.BaronP.PolskyB.JiangX.-J.Matulic-AdamicJ.RosenbergI., and WatanabeK.A. (1992) 5′-Hydrogen phosphonates and 5′-methyl phosphonates of sugar modified pyrimidine nucleosides as potential anti-HIV-1 agents. Nucleosides and Nucleotides11: 177–196.
10.
LindhI., and StawinskiJ. (1989) A general method for the synthesis of glycerophospholipids and their analogues via H-phosphonate intermediates. J Org Chem54: 1338–1342.
11.
MahmoodN., and HayA.J. (1992) An ELISA utilising immobilised snowdrop lectin GNA for the detection of envelope glycoproteins of HIVandSIV. J Immunol Meth151: 9–13.
12.
MarkV.DunganC.H.CrutchfieldM.M., and van WazerJ.R. (1969) Compilation of 31P NMR data. In Topics in Phosphorus Chemistry, Vol. 5. GraysonM., and GriffithE.J. (eds). New York: Wiley, pp. 227–456.
13.
McGuiganC.TollerfieldS.M., and RileyP.A. (1989) Synthesis and biological evaluation of some phosphate triester derivatives of the anti-viral druga araA. Nucleic Acids Res17: 6065–6075.
14.
McGuiganC.NichollsS.R.O'ConnorT.J., and KinchingtonD. (1990a) Synthesis of some novel dialkylphosphate derivatives of 3′-modified nucleosides as potential anti-AIDS drugs. Antiviral Chem Chemother1: 25–33.
15.
McGuiganC.O'ConnorT.J.NichollsS.R.NicksonC., and KinchingtonD. (1990b) Synthesis and anti-HIV activity of some novel substituted dialkyl phosphate derivatives of AZT and ddCyd. Antiviral Chem Chemother1: 355–360.
16.
McGuiganC.DevineK.G.O'ConnorT.J.GalpinS.A.JeffriesD.J., and KinchingtonD. (1990c) Synthesis and evaluation of some novel phosphoramidate derivatives of 3′-azido-3′-deoxythymidine. Antiviral Chem Chemother1: 107–113.
17.
McGuiganC.DevineK.G.O'ConnorT.J., and KinchingtonD. (1991) Synthesis and anti-HIV activity of some haloalkyl phosphoramidate derivatives of 3′-azido-3′-deoxythymidine (AZT): potent activity of the trichloroethyl methoxyalaninyl compound. Antiviral Res15: 255–263.
18.
McGuiganC.PathiranaR.N.MahmoodN.DevineK.G., and HayA.J. (1992a) Aryl phosphate derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZT. Antiviral Res16: 311–321.
19.
McGuiganC.NicksonC.PetrikJ., and KarpasA. (1992b) Phosphate derivatives of AZT display enhanced selectivity of action against HIV1 by comparison to the parent nucleoside. FESS Lett310: 171–174.
20.
McGuiganC.PathiranaR.N.BalzariniJ., and De ClercqE. (1993) Intracellular delivery of bio-active AZT nucleotides by aryl phosphate derivatives of AZT. J Med Chem36: 1048–1052.
21.
MitsuyaH.WeinholdK.J.FurmanP.A.St. ClairM.H.Nusinoff-LehrmanS.GalloR.C.BolognesiD.BarryD.W., and BroderS. (1985) 3′-Azido-3′-deoxythymidine (BWA509U): An agent that inhibits the infectivity and cytopathic effect of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci USA82: 7096–7100.
22.
PauwelsR.BalzariniJ.BabaM.SnoeckR.ScholsD.HerdewijnP.DesmeyterJ., and De ClercqE. (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Meth20: 309–321.
23.
RobertsN.A.MartinJ.A.KinchingtonD.BroadhurstA.V.CraigJ.C.DuncanI.B.GalpinS.A.HandaB.K.KayJ.KrohnA.LambertR.W.MerrettJ.H.HillsJ.S.ParkesK.E.B.RedshawS.RitchieA.J.TaylorD.L.ThomasG.T., and MachinP.J. (1990) Rational design of peptide-based HIV proteinase inhibitors. Science248: 358–361.
24.
StawinskiJ.ThelinM.WestmanE.ZainR. (1990) Nucleoside H-phosphonates. 12. Synthesis of nucleoside (3′-hydrogen phosphonothioate) monoesters via phosphinate intermediates. J Org Chem55: 3503–3506.
25.
van WazerJ.R.CallisC.F.ShooleryJ.N. (1956) Analysis of phosphorus compounds. Anal Chem28: 269–270.
